Cepheid Boosts Diagnostics Business with PCR Licensing Deals, New VP Hire | GenomeWeb

With a series of small moves in the licensing and personnel area, in recent weeks Cepheid has pointed its bow firmly toward the clinical diagnostics star.

On June 23, the Sunnyvale, Calif., company announced that it had obtained a non-exclusive license to Applera’s Real-Time PCR apparatus patents for its SmartCycler and GeneXpert RT-PCR thermal cyclers, enabling it to sell these instruments into the human diagnostics field with the exception of HIV and Hepatitis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.